Watch to learn from an expert gastroenterologist about strategies and treatment options to manage symptoms, disease flare-ups, and extra-intestinal manifestations of Inflammatory Bowel Diseases (IBD). Topics include treatment options, diarrhea and urgency, pain, fatigue or lack of energy, arthritis, mouth ulcers or sores, eye and skin conditions, and more.

0:00 Introduction
3:36 Speaker’s introduction: Dr. John Marshall
5:39 The impact of inflammatory bowel disease in Canada 2018: Epidemiology
7:09 Window of opportunity: Early intervention can slow disease progression in Crohn’s disease
8:22 Poor correlation between symptoms and endoscopy in Crohn’s disease
9:20 Treat-to-target concept in IBD
10:45 How do healthcare providers determine when it would be best to transition from a 5-ASA to a biologic or immunosuppressant?
12:00 Goals of care: inflammatory bowel disease
14:04 Treating to target in IBD: STRIDE working group
15:10 Symptoms being demoted in IBD literature
16:42 So what do IBD patients really care about?
18:32 MyGut mobile app
20:05 Audience poll question #1
21:21 Diarrhea and urgency
27:50 Abdominal Pain
33:08 Fatigue
35:46 Audience poll question #2
37:03 Extra-intestinal manifestations of IBD
37:27 Oral canker sores (aphthous ulcers)
39:30 Arthritis in IBD
41:42 Sulfasalazine
42:23 Skin conditions in IBD
43:36 Dermatologic complications of anti-TNF therapy
44:58 Eye conditions in IBD
45:55 Stress and anxiety
47:43 IMAGINE study
48:14 IBD therapeutic menu now…and soon to come
49:03 Question & Answer period
49:53 What types of cancer are most common in people with IBD and what are the causes?
51:29 How to participate in the IMAGINE study?
52:34 How can I reduce bloating and discomfort from complications in the GI tract (e.g. bacterial growth, surgery)
54:04 Why do I bleed from the rectum? What can I do to treat this?
55:07 Do you have any tips or general advice for managing fistulas?
57:00 Is there a relationship between diet and the occurrence or severity of fistulas and abscesses?
57:51 Closing remarks

Speaker:
Dr. John Marshall (MD, MSc, FRCPC, AGAF) is a Professor of Medicine and Director of the Division of Gastroenterology at McMaster University, as well as a gastroenterologist at Hamilton Health Sciences in Hamilton Ontario. He is a Full Member of the Farncombe Family Digestive Health Research Institute.

Dr. Marshall's publications include over 200 academic papers and book chapters and over 250 abstracts. He was a recipient of the Canadian Association of Gastroenterology Young Investigator Award (2008) and Educator Award (2006), and Fellowship in both the American Gastroenterological Association (2007) and the Canadian Association of Gastroenterology (2020).

Dr. Marshall and Dr. Narula are implementing MyGut, a digital program that allows patients and healthcare teams to monitor a patients' disease between visits. The electronic reporting tool also gives healthcare providers more detailed information during visits with patients. Once the MyGut program undergoes pilot testing, it will be available nationally to IBD healthcare providers and their patients. The MyGut program is a Crohn's and Colitis Canada's Promoting Access and Centres of Excellence (PACE) initiative.

For more information, please visit our website at www.crohnsandcolitis.ca/gls.

свернуть